Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

Background: For Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST1.1), measuring up to two target lesions per organ is an arbitrary criterion. Objectives: We sought to compare response assessment using RECIST1.1 and modified RECIST1.1 (mRECIST1.1, measuring the single largest lesion p...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Li-Na He, Tao Chen, Sha Fu, Yongluo Jiang, Xuanye Zhang, Chen Chen, Wei Du, Linfeng Luo, Anlin Li, Yixing Wang, Hui Yu, Yixin Zhou, Yuhong Wang, Yunpeng Yang, Yan Huang, Hongyun Zhao, Wenfeng Fang, Li Zhang, Shaodong Hong
Format:	Artigo
Sprog:	Inglês
Udgivet:	SAGE Publishing 2023-10-01
Serier:	Therapeutic Advances in Medical Oncology
Online adgang:	https://doi.org/10.1177/17588359231200463
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!